Hamilton Thorne (HTLZF) Stock Price, News & Analysis

Company Overview

Hamilton Thorne Ltd. is a life sciences instrumentation company specializing in precision laser and imaging systems used in assisted reproduction and cell analysis applications. The company’s core focus lies in providing advanced tools for in vitro fertilization (IVF) laboratories, research institutions and biotechnology firms, offering solutions that enhance embryo manipulation, sperm immobilization and cell viability assessments.

The company’s product portfolio centers on micromanipulation laser systems designed for tasks such as assisted hatching, embryo biopsy for pre-implantation genetic diagnosis, and zona drilling, enabling embryologists to perform delicate procedures with high accuracy. In addition to its laser platforms, Hamilton Thorne offers imaging and analysis software that streamlines cell counting, colony analysis and viability studies, supporting both clinical workflows and basic research in reproductive and stem cell biology.

Headquartered in Beverly, Massachusetts, Hamilton Thorne serves a global customer base through a network of offices and distribution partners across North America, Europe and Asia Pacific. Under the leadership of Chief Executive Officer Michael Spinella, the company continues to invest in product development and strategic partnerships aimed at broadening the adoption of its technologies in fertility clinics, academic laboratories and pharmaceutical research settings.

Key Stats

• Today's Range: $1.59 to $1.59
• 50-Day Range: $1.59 to $1.59
• 52-Week Range: $0.90 to $1.63
• Volume: N/A
• Average Volume: 29,614 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HTLZF
• CIK: N/A
• Web: www.hamiltonthorne.ltd
• Phone: (978) 921-2050
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A